Mechanisms of uptake of gallium by human neuroblastoma cells and effects of gallium and aluminum on cell growth, lysosomal protease, and choline acetyl transferase activity

Experimental Neurology

Volumn 153, Issue 2, 1998, Pages 342-350

  Dobson, Curtis B ^a   Graham, Jacqueline ^a   Itzhaki, Ruth F ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aluminum; Alzheimer's disease; Gallium; Human neuroblastoma cells; Lysosomal protease; Neurotoxicology

Indexed keywords

ALUMINUM; CHOLINE ACETYLTRANSFERASE; DEFEROXAMINE; GALLIUM; PROTEINASE; THYMIDINE; TRANSFERRIN;

ALZHEIMER DISEASE; ARTICLE; CELL GROWTH; COMPLEX FORMATION; ENZYME ACTIVITY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; INTERNALIZATION; LYSOSOME MEMBRANE; NEUROBLASTOMA CELL; NEUROTOXICOLOGY; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032191979     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6885     Document Type: Article

References (65)

1. Battistuzzi G., Calzolai L., Messori L., Sola M. Metal-induced conformational heterogeneity of transferrins: A spectroscopic study of indium (III) and other metal (III)-substituted transferrins. Biochem. Biophys. Res. Commun. 206:1995;161-170.
2. Bjertness E., Candy J. M., Torvik A., Ince P., McArthur F., Taylor G. A. Content of brain aluminium is not elevated in Alzheimer's disease. Alzheimer Dis. Assoc. Disord. 10:1996;171-174.
3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Candy J. M., Klinowski J., Perry R. H., Perry E. K., Fairbairn A., Oakley A. E., Carpenter T. A., Atack J. R., Blessed G., Edwardson J. A. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet. i:1986;354-357.
5. Cataldo A. M., Hamilton D. J., Barnett J. L., Paskevich P. A., Nixon R. A. Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16:1996;186-199.
6. Chitamber C. R., Zivkovic Z. Uptake of gallium-67 by human leukemic cells: Demonstration of transferrin receptor-dependent and transferrin-independent mechanisms. Cancer Res. 47:1987;3929-3934.
7. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C. Gene dose of apolipoprotein E type 2 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
8. Crapper-McLachlan D. R., Dalton A. J., Kruck T. P. A., Bell M. Y., Smith W. L., Kalow W., Andrews D. F. Intramuscular injections of desferrioxamine in patients with Alzheimer's disease. Lancet. 337:1991;1304-1308.
9. De Roo M., Hoogmartens M., Van der Schueren B., De Geest G. Autoradiographic study of tumor tracer accumulation in experimental infectious lesions. Int. J. Nucl. Med. Biol. 5:1978;104-109.
10. Dobson C. B., Graham J., Itzhaki R. F. Usage of Ga as a model for Al localisation in human neuroblastoma cells. Biochem. Soc. Trans. 23:1995;598.
11. Dominguez M. C., Sole E., Goni C., Ballabriga A. Effect of aluminum and lead salts on lipid peroxidation and cell survival in human skin fibroblasts. Biol. Trace Elem. Res. 47:1995;57-67.
12. Dreyer R. N., Bausch K. M., Fracasso P., Hammond L. J., Wunderlich D., Wirak D. O., Davis G., Brini C. M., Buckholz T. M., König G., Kamarck M. E., Tamburini P. P. Processing of the pre-β-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. Eur. J. Biochem. 224:1994;265-271.
13. Edwardson J. A., Moore P. B., Ferrier I. N., Lilley J. S., Newton G. W. A., Barker J., Templar J., Day J. P. Effect of silicon on gastrointestinal absorption of aluminium. Lancet. 342:1993;211-212.
14. Exley C., Schley L., Murray S., Hackney C. M., Birchall J. D. Aluminum, β-amyloid and non-enzymatic glycosylation. FEBS Lett. 364:1995;182-184.
15. Farrar G., Altmann P., Welch S., Wychrij O., Ghose B., Lejeune J., Corbett J., Prasher V., Blair J. A. Defective gallium-transferrin binding in Alzheimer's disease and Down syndrome: Possible mechanism for accumulation of Al in brain. Lancet. 335:1990;747-750.
16. Farrar G., Morton A. P., Blair J. P. The intestinal absorption and tissue distribution of aluminium, gallum and scandium: A comparative study. Biochem. Soc. Trans. 15:1987;1164-1165.
17. Florence A. L., Gauthier A., Ward R. J., Crichton R. R. Influence of hydroxypyridones and desferrioxamine on the mobilisation of aluminium from tissues of aluminium-loaded rats. Neurodegeneration. 4:1995;449-455.
18. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-405.
19. Ganrot P. O. Metabolism and possible health effects of aluminium. Environ. Health Perspect. 65:1986;363-441.
20. Goate A., Chartier-Harlin M., Mullan M., Brown J., Crawford F., Fidani L. Segregation of a missense mutation in the amyloid precurser protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
21. Guy S. P., Jones D., Mann D., Itzhaki R. F. Human neuroblastoma cells treated with aluminium express an epitope associated with Alzheimer's disease neurofibrillary tangles. Neurosci. Lett. 121:1991;166-168.
22. Harrington C. R., Wischik C. M., McArthur F. K., Taylor G. A., Edwardson J. A., Candy J. M. Alzheimer's-disease-like changes in tau protein processing: Association with aluminium accumulation in brains of renal dialysis patients. Lancet. 343:1994;993-997.
23. Itzhaki R. F. The aetiology of Alzheimer's disease. Molecular and Cell Biology of Neuropsychiatric Diseases. 1994;Chapman & Hall, London. p. 55-91.
24. Itzhaki R. F., Lin W., Shang D., Wilcock G. K., Faragher B., Jamieson G. A. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet. 349:1997;241-244.
25. Jones T. R., Antonetti D. L., Reid T. W. Aluminum ions stimulate mitosis in murine cells in tissue culture. J. Cell. Biochem. 30:1986;31-39.
26. King S. J. Development and application of accelerator mass-spectrometry for studies of aluminium biochemistry. 1996;University of Manchester.
27. Kute T. E., Shao Z., Sugg N. K., Long R. T., Russell G. B., Case L. D. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res. 52:1992;5198-5203.
28. Ladror U. S., Snyder S. W., Wang G. T., Holzman T. F., Krafft G. A. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-b by cathepsin D. J. Biol. Chem. 269:1994;18422-18428.
29. Landsberg J. P., McDonald B., Watt F. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature. 360:1992;65-68.
30. Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
31. Lloyd J. B., Cable H., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmacol. 41:1990;1361-1363.
32. Manfredi O. L., Weiss L. R. Gallium-67 citrate in tumors. Ultrastructural localisation by autoradiography. N. Y. State J. Med. 78:1978;884-887.
33. McGregor S. J., Naves M. L., Oria R., Vass J. K., Brock J. H. Effect of aluminium on iron uptake and transferrin-receptor expression by human erythroleukaemia K562 cells. Biochem. J. 272:1990;377-382.
34. McGregor S. J., Brock J. H., Halls D. The role of transferrin and citrate in cellular uptake of aluminium. Biol. Metals. 4:1991;173-175.
35. McGregor S. J., Brock J. H. Effect of pH and citrate on binding of iron and gallium by transferrin in serum. Clin. Chem. 38:1992;1883-1885.
36. 6755. J. Neurochem. 58:1992;898-902.
37. Nicoll J. A. R., Roberts G. W., Graham D. I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid β-protein following head injury. Nat. Med. 1:1995;135-137.
38. Nixon R. A., Cataldo A. M. The endosomal-lysosomal system of neurons: New roles. Trends Neurosci. 18:1995;489-496.
39. Ott A., Breteler M. M. B., van Harshamp F., Claus J. J., van der Cammen T. J. M., Grobbee D. E., Hofman A. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. Br. Med. J. 310:1995;970-973.
40. Priest N. D., Newton D., Day J. P., Talbot R. J., Warner A. J. Human metabolism of aluminium-26 and gallium-67 injected as citrates. Hum. Exp. Toxicol. 14:1995;287-293.
41. Pullen R. G. L., Candy J. M., Morris C. M., Taylor G., Keith A. B., Edwardson J. A. Gallium-67 as a potential marker for aluminium transport in rat brain: Implications for Alzheimer's disease. J. Neurochem. 55:1990;251-259.
42. Radunovic A., Bradbury M. W. B. Transport of aluminium into brain - Its relation to that of gallium and iron. Life Chem. Rep. 11:1994;159-163.
43. 2667. J. Physiol. 475P:1994;154P.
44. Richardson D. R., Baker E. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: The effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake. J. Cell. Physiol. 161:1994;160-168.
45. Schuurmans Stekhoven J. H., Renkawek K., Otte-Höller I., Stols A. Exogenous aluminum accumulates in the lysosomes of cultured rat cortical neurons. Neurosci. Lett. 119:1990;71-74.
46. Selkoe D. J. Missense on the membrane. Nature. 375:1995;734.
47. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
48. Shi B., Haug A. Aluminum uptake by neuroblastoma cells. J. Neurochem. 55:1990;551-558.
49. Shin R., Lee V. M. Y., Trojanowski J. Q. Aluminum modifies the properties of Alzheimer's disease PHFτ proteinsin vivoin vitro. J. Neurosci. 14:1994;7221-7233.
50. Sohn M., Jones B. J., Whiting J. H., Datz F. L., Lynch R. E., Morton K. A. Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice. J. Nucl. Med. 34:1993;2135-2143.
51. Suzuki H., Takeda M., Nakamara Y., Tada K., Hariguchi S., Nishimura T. Activities of lysosomal enzymes in rabbit brain with experimental neurofibrillary changes. Neurosci. Lett. 89:1988;234-239.
52. Swartzendruber D. C., Nelson B., Hayes R. L. Gallium-67 localisation in lysosomal-like granules of leukemic and nonleukemic murine tissues. J. Natl. Cancer. Inst. 46:1971;941-947.
53. Tagawa K., Maruyama K., Ishiura S. Amyloid b/A4 precursor protein (APP) processing in lysosomes. Ann. N. Y. Acad. Sci. 674:1992;129-137.
54. Tang M., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet. 348:1996;429-432.
55. Tartakoff A. M. A rapid radiochemical method for the determination of choline acetyltransferase. The Secretory and Endocytotic Paths. 1987;Wiley, Chichester. p. 172-173.
56. Thompson J. M., London E. D., Johnson J. E. Ultrastructural, functional, and biochemical characteristics of mouse and human neuroblastoma cell lines. Neuroscience. 7:1982;1807-1815.
57. Tokutake S., Nagase H., Morisaki S., Oyanagi S. Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate. Neurosci. Lett. 185:1995;99-102.
58. Trapp G. A. Plasma aluminium is bound to transferrin. Life Sci. 33:1983;311-316.
59. Tsuchiya Y., Nakao A., Komatsu T., Yamamoto M., Shimokata K. Relationship between gallium 67 citrate scanning and transferrin receptor expression in lung diseases. Chest. 102:1992;530-534.
60. Van Leeuwen-Stok A. E., Dräger A. M., Schuurhuis G. J., Platier A. W. J., Teule G. J. J., Huijgens P. C. Gallium 67 in the human lymphoid cell line U-715: Uptake cytotoxicity and intracellular localisation. Int. J. Radiat. Biol. 64:1993;749-759.
61. 67. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;507-517.
62. Yao X., Jenkins E. C., Wisniewski H. M. Effect of aluminum chloride on mitogenesis, mitosis, and cell cycle in human short-term whole blood cultures: Lower concentrations enhance mitosis. J. Cell. Biochem. 54:1994;473-477.
63. Yokel R. A. Aluminum chelation: Chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine. J. Toxicol. Environ. Health. 41:1994;131-174.
64. Zimmerman W. F., Godchaux W. III, Belkin M. The relative proportions of lysosomal enzyme activities in bovine retinal epithelium. Exp. Eye Res. 36:1983;151-158.
65. Dobson, C. B. et al., 1998, Toxicol. Appl. Pharmacol.